Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05174533

Acronym

SCHIZO-CV

Enrollment

Registered

2021-12-30

Start date

2022-01-12

Completion date

2022-07-12

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

schizophrenia, cardiovascular disorders, prevalence

Brief summary

Schizophrenia is a psychiatric disorder, affecting 600,000 patients in France. Patients with schizophrenia have life expectancy decrease from 10 to 20 years because of cardiovascular death. Cardiovascular risk factors are numerous: inadequate diet, smoking, alcohol consumption, diabetes, obesity. Primary prevention of cardiovascular risk in patients suffering from schizophrenia is difficult because of understaff in general practitioners and psychiatrists.

Detailed description

The aim of the study is to describe prevalence of cardiovascular disorders in patients aged 40 and more with schizophrenia.

Interventions

OTHERData collection

electrocardiogram

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

* male or female * aged of 40 and more * with schizophrenia * agreeing to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
QRS morphology	Day 0	variation of QRS waves according a standard 12-lead ECG

Secondary

Measure	Time frame	Description
cardiac rhythm	Day 0	cardiac rhythm disorder according a standard 12-lead ECG

Countries

France

Contacts

Primary ContactCURRS Université de Reims Champagne-Ardenne

currs@univ-reims.fr0326918822

Backup ContactCoralie BARBE, MD